A 5′ distal palindrome within the mouse mammary tumor virus-long terminal repeat recruits a mammary gland-specific complex and is required for a synergistic response to progesterone plus prolactin

Journal of Molecular Endocrinology

Volumn 41, Issue 1-2, 2008, Pages 75-90

  Morabito, Joseph E ^a   Trott, Josephine F ^a,b   Korz, Dorian M ^a   Fairfield, Heather E ^a,c   Buck, Sarah H ^a   Hovey, Russell C ^a,b  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WAKE FOREST UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; DNA; JANUS KINASE 2; PROGESTERONE; PROGESTERONE RECEPTOR; PROLACTIN; PROLACTIN RECEPTOR; PROTEIN KINASE FYN; THREONINE; TRANSCRIPTION FACTOR;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CONTROLLED STUDY; DOWNSTREAM PROCESSING; ENHANCER REGION; GENE DELETION; HORMONAL REGULATION; HORMONE PROTEIN COMPLEX; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; LONG TERMINAL REPEAT; MAMMARY GLAND; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; RAT; TRANSCRIPTION INITIATION; ANIMAL; BREAST TUMOR; DRUG EFFECT; DRUG POTENTIATION; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; METABOLISM; MUTATION; PATHOLOGY; PROTEIN BINDING; TUMOR CELL LINE;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; DRUG SYNERGISM; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENHANCER ELEMENTS, GENETIC; HUMANS; MAMMARY GLANDS, HUMAN; MAMMARY TUMOR VIRUS, MOUSE; MICE; MUTATION; PROGESTERONE; PROLACTIN; PROTEIN BINDING; TERMINAL REPEAT SEQUENCES; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 51349098247     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/JME-08-0027     Document Type: Article

References (98)

1. Acha-Orbea H, Finke D, Attinger A, Schmid S, Wehrli N, Vacheron S, Xenarios I, Scarpellino L, Toellner KM, MacLennan IC et al. 1999 Interplays between mouse mammary tumor virus and the cellular and humoral immune response. Immunological Reviews 168 287-303.
2. von der Ahe D, Janich S, Scheidereit C, Renkawitz R, Schutz G & Beato M 1985 Glucocorticoid and progesterone receptors bind to the same sites in two hormonally regulated promoters. Nature 313 706-709.
3. Al-Sakkaf KA, Dobson PR & Brown BL 1997 Prolactin induced tyrosine phosphorylation of p59fyn may mediate phosphatidylinositol 3-kinase activation in Nb2 cells. Journal of Molecular Endocrinology 19 347-350.
4. Asselin-Labat ML, Sutherland KD, Barker H, Thomas R, Shackleton M, Forrest NC, Hartley L, Robb L, Grosveld FG, van der Wees J et al. 2007 Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nature Cell Biology 9 201-209.
5. Ball RK, Friis RR, Schoenenberger CA, Doppler W & Groner B 1988 Prolactin regulation of beta-casein gene expression and of a cytosolic 120-kd protein in a cloned mouse mammary epithelial cell line. EMBO Journal 7 2089-2095.
6. Biola A, Lefebvre P, Perrin-Wolff M, Sturm M, Bertoglio J & Pallardy M 2001 Interleukin-2 inhibits glucocorticoid receptor transcriptional activity through a mechanism involving STAT5 (signal transducer and activator of transcription 5) but not AP-1. Molecular Endocrinology 15 1062-1076.
7. Boot LM, Muhlbock O & Ropcke G 1962 Prolactin and the induction of mammary tumors in mice. General and Comparative Endocrinology 2 601-602.
8. Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72 248-254.
9. Brisken C, Park S, Vass T, Lydon JP, O'Malley BW & Weinberg RA 1998 A paracrine role for the epithelial progesterone receptor in mammary gland development. PNAS 95 5076-5081.
10. Buser AC, Gass-Handel EK, Wyszomierski SL, Doppler W, Leonhardt SA, Schaack J, Rosen JM, Watkin H, Anderson SM & Edwards DP 2007 Progesterone receptor repression of prolactin/signal transducer and activator of transcription 5-mediated transcription of the beta-casein gene in mammary epithelial cells. Molecular Endocrinology 21 106-125.
11. Campbell GS, Argetsinger LS, Ihle JN, Kelly PA, Rillema JA & Carter-Su C 1994 Activation of JAK (JAK2) tyrosine kinase by prolactin receptors in NB (NB2) cells and mouse mammary gland explants. PNAS 91 5232-5236.
12. Cato AC, Henderson D & Ponta H 1987 The hormone response element of the mouse mammary tumour virus DNA mediates the progestin and androgen induction of transcription in the proviral long terminal repeat region. EMBO Journal 6 363-368.
13. Clevenger CV & Medaglia MV 1994 The protein tyrosine kinase p59fyn is associated with prolactin (PRL) receptor and is activated by PRL stimulation of T-lymphocytes. Molecular Endocrinology 8 674-681.
14. Daniel JC Jr, Jetton AE & Chilton BS 1984 Prolactin as a factor in the uterine response to progesterone in rabbits. Journal of Reproduction and Fertility 72 443-452.
15. Danielson KG, Oborn CJ, Durban EM, Butel JS & Medina D 1984 Epithelial mouse mammary cell line exhibiting normal morphogenesis in vivo and functional differentiation in vitro. PNAS81 3756-3760.
16. Dittrich E, Haft CR, Muys L, Heinrich PC & Graeve L 1996 A di-leucine motif and an upstream serine in the interleukin-6 (IL-6) signal transducer gp130 mediate ligand-induced endocytosis and down-regulation of the IL-6 receptor. Journal of Biological Chemistry 271 5487-5494.
17. Djiane J & Durand P 1977 Prolactin-progesterone antagonism in self regulation of prolactin receptors in mammary gland. Nature 266 641-643.
18. Dusing MR & Wiginton DA 2005 Epithelial lineages of the small intestine have unique patterns of GATA expression. Journal of Molecular Histology 36 15-24.
19. Edwards DP, Wardell SE & Boonyaratanakornkit V 2002 Progesterone receptor interacting coregulatory proteins and cross talk with cell signaling pathways. Journal of Steroid Biochemistry and Molecular Biology 83 173-186.
20. Etkind P, Du J, Khan A, Pillitteri J & Wiernik PH 2000 Mouse mammary tumor virus-like ENV gene sequences in human breast tumors and in a lymphoma of a breast cancer patient. Clinical Cancer Research 6 1273-1278.
21. Faedo M, Ford CE, Mehta R, Blazek K & Rawlinson WD 2004 Mouse mammary tumor-like virus is associated with p53 nuclear accumulation and progesterone receptor positivity but not estrogen positivity in human female breast cancer. Clinical Cancer Research 10 4417-4419.
22. Fluck CE & Miller WL 2004 GATA-4 and GATA-6 modulate tissue-specific transcription of the human gene for P450c17 by direct interaction with Sp1. Molecular Endocrinology 18 1144-1157.
23. Ford CE, Tran D, Deng Y, Ta VT, Rawlinson WD & Lawson JS 2003 Mouse mammary tumor virus-like gene sequences in breast tumors of Australian and Vietnamese women. Clinical Cancer Research 9 1118-1120.
24. Fresno Vara JA, Carretero MV, Geronimo H, Ballmer-Hofer K & Martin-Perez J 2000 Stimulation of c-Src by prolactin is independent of Jak2. Biochemical Journal 345 17-24.
25. Fresno Vara JA, Caceres MA, Silva A & Martin-Perez J 2001 Src family kinases are required for prolactin induction of cell proliferation. Molecular Biology of the Cell 12 2171-2183.
26. Gowland PL & Buetti E 1989 Mutations in the hormone regulatory element of mouse mammary tumor virus differentially affect the response to progestins, androgens, and glucocorticoids. Molecular and Cellular Biology 9 3999-4008.
27. Grimm SL & Nordeen SK 1998 Mouse mammary tumor virus sequences responsible for activating cellular oncogenes. Journal of Virology 72 9428-9435.
28. Grimm SL & Nordeen SK 1999 A composite enhancer element directing tissue-specific expression of mouse mammary tumor virus requires both ubiquitous and tissue-restricted factors. Journal of Biological Chemistry 274 12790-12796.
29. Gross DS & Garrard WT 1988 Nuclease hypersensitive sites in chromatin. Annual Review of Biochemistry 57 159-197.
30. Gunzburg WH & Salmons B 1992 Factors controlling the expression of mouse mammary tumour virus. Biochemical Journal 283 625-632.
31. Ham J, Thomson A, Needham M, Webb P & Parker M 1988 Characterization of response elements for androgens, glucocorticoids and progestins in mouse mammary tumour virus. Nucleic Acids Research 16 5263-5276.
32. Haraguchi S, Good RA, Engelman RW & Day NK 1992 Human prolactin regulates transfected MMTV LTR-directed gene expression in a human breast-carcinoma cell line through synergistic interaction with steroid hormones. International Journal of Cancer 52 928-933.
33. Haraguchi S, Good RA & Day NK 1993 Prolactin acts on the extreme 5′ portion of MMTV LTR involving a mammary cell-specific enhancer. Molecular and Cellular Endocrinology 96 R1-R6.
34. Haraguchi S, Good RA, Engelman RW, Greene S & Day NK 1997 Prolactin, epidermal growth factor or transforming growth factor-α activate a mammary cell-specific enhancer in mouse mammary tumor virus-long terminal repeat. Molecular and Cellular Endocrinology 129 145-155.
35. Haslam SZ, Osuch JR, Raafat AM & Hofseth LJ 2002 Postmenopausal hormone replacement therapy: effects on normal mammary gland in humans and in a mouse postmenopausal model. Journal of Mammary Gland Biology and Neoplasia 7 93-105.
36. Hassan MH, Khatoon N, Curiel DT, Hamada FM, Arafa HM & Al-Hendy A 2008 Toward gene therapy of uterine fibroids: targeting modified adenovirus to human leiomyoma cells. Human Reproduction 23 514-524.
37. Henrard D & Ross SR 1988 Endogenous mouse mammary tumor virus is expressed in several organs in addition to the lactating mammary gland. Journal of Virology 62 3046-3049.
38. Hewetson A & Chilton BS 2003 An Sp1-NF-Y/progesterone receptor DNA binding-dependent mechanism regulates progesterone-induced transcriptional activation of the rabbit RUSH/SMARCA3 gene. Journal of Biological Chemistry 278 40177-40185.
39. Hewetson A, Hendrix EC, Mansharamani M, Lee VH & Chilton BS 2002 Identification of the RUSH consensus-binding site by cyclic amplification and selection of targets: demonstration that RUSH mediates the ability of prolactin to augment progesterone-dependent gene expression. Molecular Endocrinology 16 2101-2112.
40. Hoch RV, Thompson DA, Baker RJ & Weigel RJ 1999 GATA-3 is expressed in association with estrogen receptor in breast cancer. International Journal of Cancer 84 122-128.
41. Horoszewicz JS, Leong SS, Chu TM, Wajsman ZL, Friedman M, Papsidero L, Kim U, Chai LS, Kakati S, Arya SK et al. 1980 The LNCaP cell line - a new model for studies on human prostatic carcinoma. Progress in Clinical and Biological Research 37 115-132.
42. Horwitz KB & Freidenberg GR 1985 Growth inhibition and increase of insulin receptors in antiestrogen-resistant T47DCO human breast cancer cells by progestins: implications for endocrine therapies. Cancer Research 45 167-173.
43. Hovey RC & Vonderhaar BK 2000 Application of in situ PCR to studies of the mammary gland. In Methods in Mammary Gland Biology and Breast Cancer Research, pp 223-232. Eds MM Ip & BB Asch. New York: Kluwer Academic.
44. Hovey RC, Trott JF, Ginsburg E, Goldhar A, Sasaki MM, Fountain SJ, Sundararajan K & Vonderhaar BK 2001 Transcriptional and spatiotemporal regulation of prolactin receptor mRNA and cooperativity with progesterone receptor function during ductal branch growth in the mammary gland. Developmental Dynamics 222 192-205.
45. Hovev RC, Trott JF & Vonderhaar BK 2002 Establishing a framework for the functional mammary gland: from endocrinology to morphology. Journal of Mammary Gland Biology and Neoplasia 7 17-38.
46. Hovey RC, Harris J, Hadsell DL, Lee AV, Ormandy CJ & Vonderhaar BK 2003 Local insulin-like growth factor-II mediates prolactin-induced mammary gland development. Molecular Endocrinology 17 460-471.
47. Hsu CL, Fabritius C & Dudley J 1988 Mouse mammary tumor virus proviruses in T-cell lymphomas lack a negative regulatory element in the long terminal repeat. Journal of Virology 62 4644-4652.
48. Hua W, Christianson T, Rougeot C, Rochefort H & Clinton GM 1995 SKOV3 ovarian carcinoma cells have functional estrogen receptor but are growth-resistant to estrogen and antiestrogens. Journal of Steroid Biochemistry and Molecular Biology 55 279-289.
49. Imagawa W, Bandyopadhyay GK & Nandi S 1990 Regulation of mammary epithelial cell growth in mice and rats. Endocrine Reviews 11 494-523.
50. Indik S, Gunzburg WH, Salmons B & Rouault F 2005 Mouse mammary tumor virus infects human cells. Cancer Research 65 6651-6659.
51. Jones EA, Conover J & Symes AJ 2000 Identification of a novel gp130-responsive site in the vasoactive intestinal peptide cytokine response element. Journal of Biological Chemistry 275 36013-36020.
52. Kouros-Mehr H, Slorach EM, Sternlicht MD & Werb Z 2006 GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell 127 1041-1055.
53. Kusk P, John S, Fragoso G, Michelotti J & Hager GL 1996 Characterization of an NF-1/CTF family member as a functional activator of the mouse mammary tumor virus long terminal repeat 5′ enhancer. Journal of Biological Chemistry 271 31269-31276.
54. Lange CA 2004 Making sense of cross-talk between steroid hormone receptors and intracellular signaling pathways: who will have the last word? Molecular Endocrinology 18 269-278.
55. van Leeuwen F & Nusse R 1995 Oncogene activation and oncogene cooperation in MMTV-induced mouse mammary cancer. Seminars in Cancer Biology 6 127-133.
56. Lefebvre P, Berard DS, Cordingley MG & Hager GL 1991 Two regions of the mouse mammary tumor virus long terminal repeat regulate the activity of its promoter in mammary cell lines. Molecular and Cellular Biology 11 2529-2537.
57. Leung BS, Potter AH & Qureshi S 1981 Interaction of prolactin, estrogen and progesterone in a human mammary carcinoma cell line, CAMA-1-I cell growth and thymidine uptake. Journal of Steroid Biochemistry 15 421-427.
58. Liao L & Jaken S 1993 Effect of alpha-protein kinase C neutralizing antibodies and the pseudosubstrate peptide on phosphorylation, migration, and growth of REF52 cells. Cell Growth and Differentiation 4 309-316.
59. Liu B, Wang Y, Melana SM, Pelisson I, Najfeld V, Holland JF & Pogo BG 2001 Identification of a proviral structure in human breast cancer. Cancer Research 61 1754-1759.
60. Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery CA Jr, Shyamala G, Conneely OM & O'Malley BW 1995 Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes and Development 9 2266-2278.
61. Lydon JP, DeMayo FJ, Conneely OM & O'Malley BW 1996 Reproductive phenotypes of the progesterone receptor null mutant mouse. Journal of Steroid Biochemistry and Molecular Biology 56 67-77.
62. Lydon JP, Ge G, Kittrell FS, Medina O & O'Malley BW 1999 Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function. Cancer Research 59 4276-4284.
63. Medina D 1973 Preneoplastic lesions in mouse mammary tumorigenesis. In Methods in Cancer Research, pp 3-53. Ed H Busch. New York: Academic Press.
64. Mellentin-Michelotti J, John S, Pennie WD, Williams T & Hager GL 1994 The 5′ enhancer of the mouse mammary tumor virus long terminal repeat contains a functional AP-2 element. Journal of Biological Chemistry 269 31983-31990.
65. Migliaccio A, Piccolo D, Castoria G, Di Domenico M, Bilancio A, Lombardi M, Gong W, Beato M & Auricchio F 1998 Activation of the Src/p21ras/ Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO Journal 17 2008-2018.
66. Migliaccio A, Castoria G, Di Domenico M, de Falco A, Bilancio A, Lombardi M, Bottero D, Varricchio L, Nanayakkara M, Rotondi A et al. 2002 Sex steroid hormones act as growth factors. Journal of Steroid Biochemistry and Molecular Biology 83 31-35.
67. Mink S, Ponta H & Cato AC 1990 The long terminal repeat region of the mouse mammary tumour virus contains multiple regulatory elements. Nucleic Acids Research 18 2017-2024.
68. Mink S, Hartig E, Jennewein P, Doppler W & Cato AC 1992 A mammary cell-specific enhancer in mouse mammary tumor virus DNA is composed of multiple regulatory elements including binding sites for CTF/NFI and a novel transcription factor, mammary cell-activating factor. Molecular and Cellular Biology 12 4906-4918.
69. Mok E, Golovkina TV & Ross SR 1992 A mouse mammary tumor virus mammary gland enhancer confers tissue-specific but not lactation-dependent expression in transgenic mice. Journal of Virology 66 7529-7532.
70. Morley KL, Toohey MG & Peterson DO 1987 Transcriptional repression of a hormone-responsive promoter. Nucleic Acids Research 15 6973-6989.
71. Muhlbock O & Boot LM 1959 Induction of mammary cancer in mice without the mammary tumor agent by isografts of hypophyses. Cancer Research 19 402-412.
72. Nagasawa H, Miur K, Niki K & Namiki H 1985 Interrelationship between prolactin and progesterone in normal mammary gland growth in SHN virgin mice. Experimental and Clinical Endocrinology 86 357-360.
73. Nagasawa H, Ohta K, Nakajima K, Noguchi Y, Miura K, Niki K & Namiki H 1986 Interrelationship between pituitary and ovarian hormones in normal and neoplastic growth of mammary glands of mice. Annals of the New York Academy of Sciences 464 301-315.
74. Nusse R 1988 The int genes in mammary tumorigenesis and in normal development. Trends in Genetics 4 291-295.
75. Oakes SR, Robertson FG, Kench JG, Gardiner-Garden M, Wand MP, Green JE & Ormandy CJ 2007 Loss of mammary epithelial prolactin receptor delays tumor formation by reducing cell proliferation in low-grade preinvasive lesions. Oncogene 26 543-553.
76. Ormandy CJ, Binart N & Kelly PA 1997a Mammary gland development in prolactin receptor knockout mice. Journal of Mammary Gland Biology and Neaplasia 2 355-364.
77. Ormandy CJ, Hall RE, Manning DL, Robertson JFR, Blamey RW, Kelly PA, Nicholson RI & Sutherland RL 1997b Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancer. Journal of Clinical Endocrinology and Metabolism 82 3692-3699.
78. Pauli F, Liu Y, Kim YA, Chen PJ & Kim SK 2006 Chromosomal clustering and GATA transcriptional regulation of intestine-expressed genes in C. elegans. Development 133 287-295.
79. Ponta H, Kennedy N, Skroch P, Hynes NE & Groner B 1985 Hormonal response region in the mouse mammary tumor virus long terminal repeat can be dissociated from the proviral promoter and has enhancer properties. PNAS 82 1020-1024.
80. Proietti C, Salatino M, Rosemblit C, Carnevale R, Pecci A, Kornblihtt AR, Molinolo AA, Frahm I, Charreau EH, Schillaci R et al. 2005 Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells. Molecular and Cellular Biology 25 4826-4840.
81. Reuss FU & Coffin JM 2000 The mouse mammary tumor virus transcription enhancers for hematopoietic progenitor and mammary gland cells share functional elements. Journal of Virology 74 8183-8187.
82. Richer JK, Lange CA, Manning NG, Owen G, Powell R & Horwitz KB 1998 Convergence of progesterone with growth factor and cytokine signaling in breast cancer. Progesterone receptors regulate signal transducers and activators of transcription expression and activity. Journal of Biological Chemistry 273 31317-31326.
83. Rui H, Kirken RA & Farrar WL 1994 Activation of receptor-associated tyrosine kinase JAK2 by prolactin. Journal of Biological Chemistry 269 5364-5368.
84. Salatino M, Beguelin W, Peters MG, Carnevale R, Proietti CJ, Galigniana MD, Vedoy CG, Schillaci R, Charreau EH, Sogayar MC et al. 2006 Progestin-induced caveolin-1 expression mediates breast cancer cell proliferation. Oncogene 25 7723-7739.
85. Soule HD, Maloney TM, Wolman SR, Peterson WD Jr, Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF & Brooks SC 1990 Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Research 50 6075-6086.
86. Srivastava S, Matsuda M, Hou Z, Bailey JP, Kitazawa R, Herbst MP & Horseman ND 2003 Receptor activator of NF-kappaB ligand induction via Jak2 and Stat5a in mammary epithelial cells. Journal of Biological Chemistry 278 46171-46178.
87. Stegalkina SS, Guerrero A, Walton KD, Liu X, Robinson GW & Hennighausen L 1999 Transcription originating in the long terminal repeats of the endogenous mouse mammary tumor virus MTV-3 is activated in Stat5a-null mice and picks up hitchhiking exons. Journal of Virology 73 8669-8676.
88. Stoecklin E, Wissler M, Schaetzle D, Pfitzner E & Groner B 1999 Interactions in the transcriptional regulation exerted by Stat5 and by members of the steroid hormone receptor family. Journal of Steroid Biochemistry and Molecular Biology 69 195-204.
89. Travers PJ, Arklie JL, Trowsdale J, Patillo RA & Bodmer WF 1982 Lack of expression of HLA-ABC antigens in choriocarcinoma and other human tumor cell lines. National Cancer Institute Monographs 60 175-180.
90. Trott JF, Hovey RC, Koduri S & Vonderhaar BK 2003 Alternative splicing to exon 11 of human prolactin receptor gene results in multiple isoforms including a secreted prolactin binding protein. Journal of Molecular Endocrinology 30 31-47.
91. Wagner KU, McAllister K, Ward T, Davis B, Wiseman R & Hennighausen L 2001 Spatial and temporal expression of the Cre gene under the control of the MMTV-LTR in different lines of transgenic mice. Transgenic Research 10 545-553.
92. Wang Y, Holland JF, Bleiweiss IJ, Melana S, Liu X, Pelisson I, Cantarella A, Stellrecht K, Mani S & Pogo BG 1995 Detection of mammary tumor virus env gene-like sequences in human breast cancer. Cancer Research 55 5173-5179.
93. Wang Y, Jiang JD, Xu D, Li Y, Qu C, Holland JF & Pogo BG 2004 A mouse mammary tumor virus-like long terminal repeat super-antigen in human breast cancer. Cancer Research 64 4105-4111.
94. Wang J, Paradis P, Aries A, Komati H, Lefebvre C, Wang H & Nemer M 2005 Convergence of protein kinase C and JAK-STAT signaling on transcription factor GATA-4. Molecular and Cellular Biology 25 9829-9844.
95. Westley B & Rochefort H 1980 A secreted glycoprotein induced by estrogen in human breast cancer cell lines. Cell 20 353-362.
96. Williams CJ, Major PP & Dion AS 1990 Enhanced expression and secretion of an epithelial membrane antigen (MA5) in a human mucinous breast tumor line (BT549). Tumour Biology 11 145-157.
97. Yanagawa S, Tanaka H & Ishimoto A 1991 Identification of a novel mammary cell line-specific enhancer element in the long terminal repeat of mouse mammary tumor virus, which interacts with its hormone-responsive element. Journal of Virology 65 526-531.
98. Zhang Y, Turkson J, Carter-Su C, Smithgall T, Levitzki A, Kraker A, Krolewski JJ, Medveczky P & Jove R 2000 Activation of Stat3 in v-Src-transformed fibroblasts requires cooperation of Jak1 kinase activity. Journal of Biological Chemistry 275 24935-24944.